Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1

被引:59
|
作者
Misumi, Shogo [1 ]
Inoue, Mutsumi
Dochi, Takeo
Kishimoto, Naoki
Hasegawa, Naomi
Takamune, Nobutoki
Shoji, Shozo [1 ,2 ]
机构
[1] Kumamoto Univ, Dept Pharmaceut Biochem, Fac Med & Pharmaceut Sci, Kumamoto 8620973, Japan
[2] Kumamoto Hlth Sci Univ, Kumamoto 8615598, Japan
基金
日本学术振兴会;
关键词
2-DIMENSIONAL GEL-ELECTROPHORESIS; CYCLE-DEPENDENT PHOSPHORYLATION; FLIGHT MASS-SPECTROMETRY; HIV-1 CAPSID PROTEIN; INTRACELLULAR TRAFFICKING; IN-VITRO; CELL; INFECTION; DOMAIN; GENE;
D O I
10.1074/jbc.M110.114256
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The process by which the human immunodeficiency virus type 1 (HIV-1) conical core dissociates is called uncoating, but not much is known about this process. Here, we show that the uncoating process requires the interaction of the capsid (CA) protein with the peptidyl-prolyl isomerase Pin1 that specifically recognizes the phosphorylated serine/threonine residue followed by proline. We found that the HIV-1 core is composed of some isoforms of the CA protein with different isoelectric points, and one isoform is preferentially phosphorylated in the Ser(16)-Pro(17) motif. The mutant virus S16A/P17A shows a severely attenuated HIV-1 replication and an impaired reverse transcription. The S16A/P17A change increased the amount of particulate CA cores in the cytosol of target cells and correlated with the restriction of HIV-1 infection. Glutathione S-transferase pulldown assays demonstrated a direct interaction between Pin1 and the HIV-1 core via the Ser(16)-Pro(17) motif. Suppression of Pin1 expression by RNA interference in a target cell results in an attenuated HIV-1 replication and increases the amount of particulate CA cores in the cytosol of target cells. Furthermore, heat-inactivated, inhibitor-treated, or W34A/K63A Pin1 causes an attenuated in vitro uncoating of the HIV-1 core. The Pin1-dependent uncoating is inhibited by antisera raised against a CA peptide phosphorylated at Ser(16) or treatment of the HIV-1 core with alkaline phosphatase. These findings provide insights into this obscure uncoating process in the HIV-1 life cycle and a new cellular target for HIV-1 drug development.
引用
收藏
页码:25185 / 25195
页数:11
相关论文
共 50 条
  • [31] Inhibition of Foamy Virus Reverse Transcriptase by Human Immunodeficiency Virus Type 1 RNase H Inhibitors
    Corona, Angela
    Schneider, Anna
    Schweimer, Kristian
    Roesch, Paul
    Woehrl, Birgitta M.
    Tramontano, Enzo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 4086 - 4093
  • [32] Human immunodeficiency virus type 1, human protein interaction database at NCBI
    Fu, William
    Sanders-Beer, Brigitte E.
    Katz, Kenneth S.
    Maglott, Donna R.
    Pruitt, Kim D.
    Ptak, Roger G.
    NUCLEIC ACIDS RESEARCH, 2009, 37 : D417 - D422
  • [33] The role of IL-1β during human immunodeficiency virus type 1 infection
    Yaseen, Mahmoud M.
    Abuharfeil, Nizar M.
    Darmani, Homa
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (01)
  • [34] Regulation of human immunodeficiency virus type 1 (HIV-1) mRNA translation
    Hidalgo, Laura
    Swanson, Chad M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2017, 45 : 353 - 364
  • [35] Stereospecific NANOG PEST Stabilization by Pin1
    Ferreon, Josephine C.
    Ta, Hai Minh
    Yun, Hyosuk
    Choi, Kyoung-Jae
    Quan, My Diem
    Tsoi, Phoebe S.
    Kim, Choel
    Lee, Chul Won
    Ferreon, Allan Chris M.
    BIOCHEMISTRY, 2024, 63 (09) : 1067 - 1074
  • [36] Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate
    Wang, Xiaoli
    Wang, Jiao
    Zhang, Wenmei
    Li, Boye
    Zhu, Ying
    Hu, Qin
    Yang, Yishu
    Zhang, Xiaoguang
    Yan, Hong
    Zeng, Yi
    VIRUSES-BASEL, 2018, 10 (05):
  • [37] Aluminum(III) interferes with the structure and the activity of the peptidyl-prolyl cis-trans isomerase (Pin1): A new mechanism contributing to the pathogenesis of Alzheimer's disease and cancers?
    Wang, Jing-Zhang
    Liu, Ji
    Lin, Tao
    Han, Yong-Guang
    Luo, Yue
    Xi, Lei
    Du, Lin-Fang
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2013, 126 : 111 - 117
  • [38] Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus Type 1 Infection
    Oh, Myung Don
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2007, 50 (04): : 316 - 323
  • [39] Inhibition of human immunodeficiency virus type-1 through autophagy
    Campbell, Grant R.
    Spector, Stephen A.
    CURRENT OPINION IN MICROBIOLOGY, 2013, 16 (03) : 349 - 354
  • [40] Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
    McElrath, M. Juliana
    Haynes, Barton F.
    IMMUNITY, 2010, 33 (04) : 542 - 554